William Benton Jones

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Benton Jones:

Company Role Class Num Shares Value Price $ Report Date Ownership
Corvus Pharmaceuticals, Inc. SVP, Pharmaceutical Development Common Stock 173,130 $605,955 $3.50 04 Jun 2025 Direct
Corvus Pharmaceuticals, Inc. SVP, Pharmaceutical Development Stock Option (Right to Buy) 400,000 04 Dec 2025 Direct
Corvus Pharmaceuticals, Inc. SVP, Pharmaceutical Development Warrant (Right to Buy) 0 04 Jun 2025 Direct

Insider Reports Filed by William Benton Jones

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRVS Corvus Pharmaceuticals, Inc. 04 Dec 2025 1 $0 4 SVP, Pharmaceutical Development 08 Dec 2025, 16:23
CRVS Corvus Pharmaceuticals, Inc. 04 Jun 2025 2 +$67,750 4 SVP, Pharmaceutical Development 06 Jun 2025, 16:26
CRVS Corvus Pharmaceuticals, Inc. 20 Dec 2024 1 $0 4 SVP, Pharmaceutical Development 23 Dec 2024, 16:39
CRVS Corvus Pharmaceuticals, Inc. 06 May 2024 2 +$34,624 4 SVP, Pharmaceutical Development 07 May 2024, 17:06
CRVS Corvus Pharmaceuticals, Inc. 06 Dec 2023 1 $0 4 SVP, Pharmaceutical Development 08 Dec 2023, 16:07
CRVS Corvus Pharmaceuticals, Inc. 20 Dec 2022 1 +$15,800 4 SVP, Pharmaceutical Development 20 Dec 2022, 17:22
CRVS Corvus Pharmaceuticals, Inc. 11 Aug 2022 1 $0 4 SVP, Pharmaceutical Development 15 Aug 2022, 18:44
CRVS Corvus Pharmaceuticals, Inc. 09 Sep 2021 1 $0 4 SVP, Pharmaceutical Development 13 Sep 2021, 16:57